欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
ES/V/0341/001
药品名称
ATONYL 1.5 mg/ml SOLUTION FOR INJECTION
活性成分
Neostigmine metilsulfate 15.0 mg/ml
剂型
-
上市许可持有人
CENAVISA, S.L. Camí Pedra Estela s/n 43205 Reus (SPAIN)
参考成员国 - 产品名称
Spain (ES)
互认成员国 - 产品名称
Romania (RO)
Portugal (PT)
Latvia (LV)
Atonyl 1,5 mg/ml šķīdums injekcijām liellopiem, aitām, kazām un zirgiem
Lithuania (LT)
Hungary (HU)
Bulgaria (BG)
许可日期
2019/07/30
最近更新日期
2019/10/31
药物ATC编码
QN07AA01 neostigmine
申请类型
TypeLevel1:
food
TypeLevel2:
Pharmaceutical
TypeLevel3:
Generic - art 13.2 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Labelling
|
eu_lab_esv0341001_dc_atonyl_en
Date of last change:2024/09/06
Final PL
|
eu_pl_esv0341001_dc_atonyl_en
Date of last change:2024/09/06
Final SPC
|
eu_spc_esv0341001_dc_atonyl_en
Date of last change:2024/09/06
PubAR
|
final PuAR ATONYL solution for injection _ ES V 0341 001 DC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase